Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

L. Bergman; M. Beelen; M.P.W. Gallee; H. Hollema; J. Benraadt; F.J. van Leeuwen; L.J. Schouten

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

L. Bergman, M. Beelen, M.P.W. Gallee, H. Hollema, J. Benraadt, F.J. van Leeuwen, L.J. Schouten

NUTRIM School of Nutrition and Translational Research in Metabolism

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	887
Number of pages	881
Journal	Lancet
Volume	356
Issue number	8
Publication status	Published - 1 Jan 2000

Access to Document

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11036892&dopt=Abstract

Cite this

Bergman, L., Beelen, M., Gallee, M. P. W., Hollema, H., Benraadt, J., van Leeuwen, F. J., & Schouten, L. J. (2000). Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet, 356(8), 887. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11036892&dopt=Abstract

@article{19f7d56792fd414896e8813f77961e66,

title = "Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen",

author = "L. Bergman and M. Beelen and M.P.W. Gallee and H. Hollema and J. Benraadt and {van Leeuwen}, F.J. and L.J. Schouten",

year = "2000",

month = jan,

day = "1",

language = "English",

volume = "356",

pages = "887",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Science",

number = "8",

}

Bergman, L, Beelen, M, Gallee, MPW, Hollema, H, Benraadt, J, van Leeuwen, FJ & Schouten, LJ 2000, 'Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen', Lancet, vol. 356, no. 8, pp. 887. <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11036892&dopt=Abstract>

TY - JOUR

T1 - Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

AU - Bergman, L.

AU - Beelen, M.

AU - Gallee, M.P.W.

AU - Hollema, H.

AU - Benraadt, J.

AU - van Leeuwen, F.J.

AU - Schouten, L.J.

PY - 2000/1/1

Y1 - 2000/1/1

M3 - Article

SN - 0140-6736

VL - 356

SP - 887

JO - Lancet

JF - Lancet

IS - 8

ER -